What we do
Oral solids, with a specialism in modified release.
Modified-release pellet technology is the technical centre of the group. It is a demanding discipline, and it is the reason our formulation capability extends beyond straightforward generic tablet manufacture.
Technology
Where the specialism sits.
Modified-release pellets
Sustained-release and delayed-release pellet systems, including enteric and multi-phase release profiles, developed to a defined dissolution target rather than an approximate one.
Ready-to-fill pellets
Pellets supplied to other manufacturers for encapsulation or compression — a business line in its own right, and a useful proof that the technology travels.
Directly compressible granules
Granulations engineered for direct compression, reducing process steps and improving content uniformity for suitable molecules.
Taste-masked granules
Taste masking for molecules where palatability governs adherence — particularly relevant in paediatric and geriatric presentations.
Development services
From molecule to validated process.
| Formulation development | Excipient selection, release-profile design and prototype development against a target product profile. |
|---|---|
| Process development | Definition and refinement of the manufacturing process, including critical process parameters and control strategy. |
| Analytical methods | Method development and validation to recognised pharmacopoeial standards, including dissolution method development for modified-release profiles. |
| Stability programmes | Stability studies under defined storage conditions, with reporting appropriate to the intended market. |
| Scale-up | Progression from laboratory through pilot to commercial batch scale, with process robustness demonstrated rather than assumed. |
| Technology transfer | Transfer to a receiving site, including documentation, training and support through validation batches. |
Therapeutic areas
Where the portfolio concentrates.
The group’s formulation experience is weighted towards chronic disease and long-term therapy — the categories where modified release matters most and where continuity of supply is most consequential for a patient.
Next step
Looking for a formulation partner?
Contract development, contract manufacturing and ready-to-fill pellet supply are all live business lines.